Literature DB >> 20861593

Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.

Timothy E Wilens1, Thomas J Spencer.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is among the most common neurobehavioral disorders requiring treatment in children and adolescents. The disorder is often chronic, with prominent symptoms and impairment spanning into adulthood. It is often associated with co-occurring disorders, including disruptive, mood, anxiety, and substance abuse disorders. The diagnosis of ADHD is clinically established by review of symptoms and impairment. The biological underpinning of the disorder is supported by genetic, neuroimaging, neurochemistry, and neuropsychological data. All aspects of an individual's life need to be considered in the diagnosis and treatment of ADHD. Multimodal treatment includes educational, family, and individual support. Psychotherapy alone and in combination with medication is helpful for treating patients with ADHD and comorbid disorders. Pharmacotherapy, including stimulants, noradrenergic agents, α-agonists, and antidepressants, plays a fundamental role in the long-term management of ADHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861593      PMCID: PMC3724232          DOI: 10.3810/pgm.2010.09.2206

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  103 in total

1.  From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder?

Authors:  B J Casey; Sarah Durston
Journal:  Am J Psychiatry       Date:  2006-06       Impact factor: 18.112

2.  ADHD drugs and cardiovascular risk.

Authors:  Marsha D Rappley; John W Moore; Deborah Dokken
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

3.  Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.

Authors:  Larry J Seidman; Eve M Valera; Nikos Makris; Michael C Monuteaux; Denise L Boriel; Kalika Kelkar; David N Kennedy; Verne S Caviness; George Bush; Meg Aleardi; Stephen V Faraone; Joseph Biederman
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

4.  Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.

Authors:  Laurence Greenhill; Scott Kollins; Howard Abikoff; James McCracken; Mark Riddle; James Swanson; James McGough; Sharon Wigal; Tim Wigal; Benedetto Vitiello; Anne Skrobala; Kelly Posner; Jaswinder Ghuman; Charles Cunningham; Mark Davies; Shirley Chuang; Tom Cooper
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-11       Impact factor: 8.829

Review 5.  Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.

Authors:  Timothy E Wilens; Joseph Biederman
Journal:  J Psychopharmacol       Date:  2005-09-20       Impact factor: 4.153

Review 6.  Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Authors:  Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

7.  Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.

Authors:  Nikos Makris; Joseph Biederman; Eve M Valera; George Bush; Jonathan Kaiser; David N Kennedy; Verne S Caviness; Stephen V Faraone; Larry J Seidman
Journal:  Cereb Cortex       Date:  2006-08-18       Impact factor: 5.357

8.  Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.

Authors:  Timothy E Wilens; Martin Gignac; Allison Swezey; Michael C Monuteaux; Joseph Biederman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-04       Impact factor: 8.829

Review 9.  Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Andrea M Chronis; Heather A Jones; Veronica L Raggi
Journal:  Clin Psychol Rev       Date:  2006-02-17

Review 10.  Neuropsychological functioning in people with ADHD across the lifespan.

Authors:  Larry J Seidman
Journal:  Clin Psychol Rev       Date:  2006-02-13
View more
  58 in total

Review 1.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

Review 2.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

3.  Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Authors:  Arzu Selen; Anette Müllertz; Filippos Kesisoglou; Rodney J Y Ho; Jack A Cook; Paul A Dickinson; Talia Flanagan
Journal:  AAPS J       Date:  2020-07-27       Impact factor: 4.009

4.  Stimulant medication use in children: a 12-year perspective.

Authors:  Samuel H Zuvekas; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

5.  Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth.

Authors:  Cynthia P Paidipati; Bridgette Brawner; Ricardo Eiraldi; Janet A Deatrick
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-01-11       Impact factor: 2.385

Review 6.  The intersection of attention-deficit/hyperactivity disorder and substance abuse.

Authors:  Timothy E Wilens; Nicholas R Morrison
Journal:  Curr Opin Psychiatry       Date:  2011-07       Impact factor: 4.741

7.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

Review 8.  The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.

Authors:  Courtney A Zulauf; Susan E Sprich; Steven A Safren; Timothy E Wilens
Journal:  Curr Psychiatry Rep       Date:  2014-03       Impact factor: 5.285

Review 9.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

10.  Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

Authors:  Erin A McClure; Susan C Sonne; Theresa Winhusen; Kathleen M Carroll; Udi E Ghitza; Aimee L McRae-Clark; Abigail G Matthews; Gaurav Sharma; Paul Van Veldhuisen; Ryan G Vandrey; Frances R Levin; Roger D Weiss; Robert Lindblad; Colleen Allen; Larissa J Mooney; Louise Haynes; Gregory S Brigham; Steve Sparenborg; Albert L Hasson; Kevin M Gray
Journal:  Contemp Clin Trials       Date:  2014-08-30       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.